My Profile e-Learning Center my.ASTHO Contact Us

Displaying 5 results for

Search within results:

GO

Search Filters: Rhode Island Tobacco Control Social and Behavioral Health California

2022 Legislative Session Update: Part Two

Blog,

Health Policy Update,

Policy,

State Health Policy,

Population Health and Prevention,

Social and Behavioral Health,

STIs,

HIV,

Tobacco Control,

Mental Health,

Environmental Health,

Food and Water Safety,

PFAS,

Health Equity,

Rural Health,

Infectious Disease,

West Virginia,

Wyoming,

New Jersey,

California,

Washington, D.C.,

New York,

Colorado,

Connecticut,

Hawaii,

Illinois,

Indiana,

Rhode Island,

Minnesota,

Washington,

Maryland,

Parker Beene,

Maggie Davis,

Beth Giambrone

The ASTHO State Health Policy team provides brief updates on 5 of the ten state health policy issues to watch in 2022: mental and behavioral health, rural health, e-cigarettes and flavored tobacco products, HIV and PFAS.

Jurisdictions Moving Many ASTHO Essential Tobacco Control Policies Forward

Blog,

Health Policy Update,

Policy,

State Health Policy,

Population Health and Prevention,

Social and Behavioral Health,

Tobacco Control,

Chronic Disease Prevention and Health Improvement,

Health Equity,

Elimination of Disparities,

Alaska,

American Samoa,

California,

Florida,

Georgia,

Guam,

Hawaii,

Illinois,

Iowa,

Kentucky,

Louisiana,

Maryland,

Massachusetts,

Mississippi,

Nebraska,

New Jersey,

New Mexico,

New York,

Northern Mariana Islands,

Oregon,

Puerto Rico,

Rhode Island,

Tennessee,

Virgin Islands,

Washington,

Washington, D.C.,

West Virginia,

Wisconsin,

Joshua Berry,

Ann Abraham,

Territories and Freely Associated States,

Evidence or Fact-Based Measures

Over the past several years, states and jurisdictions have continued to implement important policies to reduce tobacco and nicotine use, including increasing tobacco prices, expanding areas deemed “smoke-free,” limiting the sale of ...

ASTHO Policy Watch 2022: E-Cigarettes and Flavored Tobacco Products

Blog,

Health Policy Update,

Policy,

State Health Policy,

Population Health and Prevention,

Social and Behavioral Health,

Tobacco Control,

Health Equity,

At-Risk Populations,

Elimination of Disparities,

California,

Illinois,

Massachusetts,

Michigan,

New Jersey,

New York,

Rhode Island,

Utah,

Washington, D.C.,

Beth Giambrone

Each year, ASTHO notes the top public health policy issues to watch in the upcoming year. ASTHO has published a prospectus on several issues, with more coming later this month. ASTHO kicked off its top 10 public health state policy issues ...

From the Chief Medical Officer: How State Health Officials Can Make a Stand Against Menthol

Blog,

People of Public Health,

Series,

Chief Medical Officer Series,

Population Health and Prevention,

Social and Behavioral Health,

Tobacco Control,

Policy,

Federal Government Affairs,

Public Health Law,

State Health Policy,

Territorial Health Policy,

Communications,

Chronic Disease Prevention and Health Improvement,

Health Equity,

At-Risk Populations,

Elimination of Disparities,

Race and Public Health,

California,

Massachusetts,

North Carolina,

Oklahoma,

Rhode Island,

Marcus Plescia

Tobacco control has been a public health success in states across the nation, but there is still work to be done, especially surrounding the popularity of menthol and other types of flavored tobacco.

COVID-19 Pandemic Underscores Need for Tobacco Control Policies

Blog,

Health Policy Update,

Population Health and Prevention,

Social and Behavioral Health,

Tobacco Control,

Infectious Disease,

COVID-19,

Health Equity,

At-Risk Populations,

Policy,

State Health Policy,

Public Health Law,

Federal Government Affairs,

California,

Massachusetts,

Utah,

Wyoming,

Andy Baker-White,

Joshua Berry,

New Jersey,

New York,

Rhode Island,

Florida,

Preparedness,

Pandemics,

Race and Public Health

The COVID-19 pandemic has further amplified the need for strong tobacco prevention and cessation policies. Research indicates that tobacco use is associated with increased rate of COVID-19 disease progression and increased likelihood of ...